sr141716 has been researched along with Breast Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bifulco, M; Fiore, D; Gazzerro, P; Proto, MC | 1 |
| Christensson, B; Flygare, J; Gustafsson, K; Kimby, E; Sander, B | 1 |
| Bifulco, M; Caruso, MG; Di Marzo, V; Grimaldi, C; Iacuzzo, I; Laezza, C; Malfitano, AM; Notarnicola, M; Pisanti, S; Portella, G; Santoro, A; Vitale, M | 1 |
| Bifulco, M; Gazzerro, P; Laezza, C; Malfitano, AM; Pisanti, S; Santoro, A; Sarnataro, D | 1 |
| De Petrocellis, L; Di Marzo, V; Galve-Roperh, I; Guzmán, M; Melck, D; Rueda, D | 1 |
| Bifulco, M; Bisogno, T; De Petrocellis, L; Di Marzo, V; Laezza, C; Melck, D; Orlando, P | 1 |
6 other study(ies) available for sr141716 and Breast Neoplasms
| Article | Year |
|---|---|
Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment.
Topics: Breast Neoplasms; Cannabidiol; Female; Humans; Melanoma, Cutaneous Malignant; Rimonabant; Tumor Microenvironment | 2023 |
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.
Topics: Animals; Arachidonic Acids; Benzoxazines; Biopsy; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Death; Cell Division; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Viral; Cells, Cultured; Dose-Response Relationship, Drug; Endocannabinoids; Female; Flow Cytometry; Humans; Leukemia, Plasma Cell; Ligands; Lymphoma, Mantle-Cell; Mice; Morpholines; Naphthalenes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Rimonabant | 2005 |
Anandamide inhibits adhesion and migration of breast cancer cells.
Topics: Animals; Apoptosis; Arachidonic Acids; Breast Neoplasms; Cannabinoid Receptor Modulators; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Dose-Response Relationship, Drug; Endocannabinoids; Female; Focal Adhesion Kinase 1; Humans; Integrins; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phosphorylation; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; src-Family Kinases; Time Factors | 2006 |
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.
Topics: Animals; Breast Neoplasms; Caveolae; Cell Cycle; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Female; Humans; MAP Kinase Signaling System; Membrane Microdomains; Mice; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Transplantation, Heterologous; Tumor Burden | 2006 |
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells.
Topics: Arachidonic Acids; Breast Neoplasms; Cell Division; Cell Line; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Endocannabinoids; Flavonoids; Humans; Mitogen-Activated Protein Kinases; Nerve Growth Factor; Piperidines; Polyunsaturated Alkamides; Prolactin; Proto-Oncogene Proteins c-raf; Pyrazoles; Receptors, Prolactin; Rimonabant; Tumor Cells, Cultured | 1999 |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Topics: Arachidonic Acids; Binding Sites; Blotting, Western; Breast Neoplasms; Cannabinoid Receptor Modulators; Cannabinoids; Cell Division; Endocannabinoids; Female; Glycerides; Humans; Male; Neoplasms, Hormone-Dependent; Nerve Growth Factors; Piperidines; Polyunsaturated Alkamides; Prostatic Neoplasms; Pyrazoles; Receptor Protein-Tyrosine Kinases; Receptors, Cannabinoid; Receptors, Drug; Receptors, Nerve Growth Factor; Receptors, Prolactin; Rimonabant; Tumor Cells, Cultured | 2000 |